Residual gastric contents (RGC) Although the overwhelming majority of articles assessed have accepted that GLP-1 RAs can significantly increase residual gastric contents by delaying gastric emptying time as scientific fact, not all have retained this belief
Phase 2 trial dosing used once-weekly subcutaneous injections with gradual escalation from 1 mg up to 12 mg to minimise gastrointestinal side effects
Despite these promising findings, most gastroenterologists acknowledge that GLP-1 medications are not yet standard-of-care treatments for IBS, and patients should discuss potential benefits and risks with their healthcare providers before starting therapy
Your glutathione solution will flow steadily over 30 to 60 minutes, depending on your dosage and individual needs
The tolerability profile of arGLP-1 in our study was favorable, with transient nausea being the most common side effect, primarily occurring during treatment initiation and dose titration
If the active ingredient degrades because of improper storage, drawing exactly 10 units may deliver less than the expected milligram amount because some of the semaglutide molecules have broken down